Featured Zone

Chapmans Limited expands footprint, announces new office in London

 Chapmans Limited expands footprint, announces new office in London

Chapmans Limited, an Australian investment company, has zeroed in on London for its new office.

Read More...
I3 Energy continues to march ahead with a robust strategy

I3 Energy continues to march ahead with a robust strategy

AIM-listed independent oil and gas company I3 Energy (LON: I3E) (TSX: ITE) has emerged as a business well-positioned for growth in the oil and gas industry. The company recently announced the completion of its first phase of drilling at its Martin...

Read More...
I3 Energy announces completion of drilling at second Martin Hills well

I3 Energy announces completion of drilling at second Martin Hills well

Summary  I3 Energy has completed the drilling of its second well at Marten Hills, 02-12-075-26W4. With this, the first phase of drilling at this acreage in Alberta, Canada, is complete. Production at this and another well, whose drilling w...

Read More...
I3 Energy: What is transpiring a continuous surge in stock prices?

I3 Energy: What is transpiring a continuous surge in stock prices?

AIM/TSX-listed independent oil and gas company I3 Energy PLC’s (LON: I3E) (TSX: ITE) shares have risen sharply by around 34 per cent in the last one month, from GBX 8.70 on 14 June to GBX 11.63 on 12 July. The shares have risen by a huge 107....

Read More...
OptiBiotix (LON: OPTI) riding high on global recognitions and credibility

OptiBiotix (LON: OPTI) riding high on global recognitions and credibility

Summary OptiBiotix Health Plc has established itself as a trusted player in the human microbiome segment. Various awards and recognition received by the Company are an endorsement of its credibility and the value of its products. OptiBiotix ha...

Read More...
D-Day: I3 Energy announces maiden dividend and successful corporate strategy execution

D-Day: I3 Energy announces maiden dividend and successful corporate strategy execution

Summary AIM-listed energy company I3 Energy (LON: I3E) announced its maiden special dividend after court cancelled its share premium account. The dividend payout of 0.16 pence per share is scheduled for 6 August, while its ex-dividend date is 1...

Read More...
I3 Energy’s Canadian acquisition to enhance production, strengthen financials

I3 Energy’s Canadian acquisition to enhance production, strengthen financials

Summary Independent energy company I3 Energy announced the asset acquisition of Canadian energy company Cenovus Energy Inc to expand its production in central Alberta core are for CA$ 65 million. I3 Energy raised at least £40 million via ...

Read More...
Reabold Resources goes from strength to strength

Reabold Resources goes from strength to strength

Reabold Resources Plc (LON: RBD), a London-based investment company focused on low risk upstream oil and gas projects, has had a fantastic stretch so far in the current calendar year in terms of investments and acquisitions, including an oversubscrib...

Read More...
I3 Energy improves Q2 production, finishes drilling in first Marten Hills well

I3 Energy improves Q2 production, finishes drilling in first Marten Hills well

I3 Energy PLC (LON: I3E) (TSX: ITE), an AIM-listed independent energy company with assets and operations in the UK and Canada, has recorded an improvement in its second-quarter production and has successfully completed the drilling process in its f...

Read More...
After court clearance, i3 Energy plc all set to announce its maiden dividend

After court clearance, i3 Energy plc all set to announce its maiden dividend

Summary The High Court of Justice of England and Wales has approved the cancellation of i3 Energy's share premium account, paving the way for the maiden dividend.  After getting confirmation from the Registrar of Companies final Ex-dividen...

Read More...
OptiBiotix Health Plc poised to capture the expanding human microbiome market

OptiBiotix Health Plc poised to capture the expanding human microbiome market

Summary The human microbiome market is projected to surge from US$ 894 million in 2025 to US$ 1,598 million by 2028 at a CAGR of 21.3 per cent. OptiBiotix has already launched various products, which are successful and have been generating good...

Read More...